Physician-Modified Fenestrated and Branched Aortic Endografting for TAAA
Recruiting now · Not applicable
Conditions studied: Aortic Aneurysm, Thoracoabdominal
In brief
The primary clinical objective of this study is to evaluate the safety and effectiveness of a physician-modified, fenestrated and branched aortic endoprosthesis for the treatment of thoracoabdominal aortic aneurysms (TAAAs). The goal of the primary analysis is to demonstrate both the safety and effectiveness of using a physician-modified fenestrated Cook Zenith Alpha Thoracic Endovascular Graft as compared to previously published results of open surgical replacement of the aneurysmal aorta.
Key facts
- Study ID
- NCT02989948
- Run by
- Yale University
- People needed
- 80
- Starts
- 2020-04-22
- Expected to finish
- 2031-12-31
- Last updated by the study team
- 2026-04-27
Who can join
Age: 50 and older, up to 95. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Yale New Haven Hospital — New Haven, Connecticut, United States (enrolling)
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.